PharmaShots | Incisive News in 3 Shots

Subscribe Now

TheracosBio

TheracosBio’s Brenzavvy (bexagliflozin) Receives the US FDA’s Approval for the Treatment of Adults with Type 2 Diabetes

TheracosBio’s Brenzavvy (bexagliflozin) Receives the US FDA’s Approval for the Treatment of Adults with Type 2 Diabetes

January 24, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us